BALVERSA®
(erdafitinib)
BALVERSA® (erdafitinib)
- Interactive ingredient checker
- Pivotal clinical trial publications
- Safety Data Sheets (SDS)
- Search medical information
- U.S. FDA grants full approval for BALVERSA® to treat locally advanced or metastatic bladder cancer with select genetic alterations
- Useful links
Contact Our Medical Experts For Your Inquiry About BALVERSA® (erdafitinib)
- Call me now
- Live chatMonday-Friday 9AM- 4:30PM ET
- Live videoMonday-Friday 9AM- 4:30PM ET
- Locate my MSL
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.